Government R&D subsidy for new drugs wasteful.

Published: 2005-10-13 06:58:00

Updated: 2005-10-13 06:58:00

Rep. Hyun Ae-jo disclosed the Korea Health Industry Development Institute(KHIDI) report covering that only 8 subjects of the new drug R&D financially supported by the government up to April 2005 had been successfully commercialized out of the total 100, and of which only 4 subjects made a technol...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK